INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

NATIXIS's Holding History (CIK: 0001274981)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 120,000 Value ($000) $2,225 Avg Close — Range —
Q2 2023
Shares 9,571 Value ($000) $106 Avg Close — Range —
Q1 2023
Shares 3,763 Value ($000) $51 Avg Close — Range —
Q4 2022
Shares 3,998 Value ($000) $49 Avg Close — Range —
Q4 2020
Shares 10,110 Value ($000) $250 Avg Close — Range —
Q4 2018
Shares 14,790 Value ($000) $1,491 Avg Close — Range —
Q3 2018
Shares 6,980 Value ($000) $882 Avg Close — Range —
Q2 2018
Shares 8,688 Value ($000) $729 Avg Close — Range —
Q4 2017
Shares 3,903 Value ($000) $228 Avg Close — Range —
Q3 2017
Shares 17,170 Value ($000) $997 Avg Close — Range —